End Payors Seek $66M In Atty Fees In Generic Drug MDL
By P.J. D'Annunzio · November 4, 2025, 4:45 PM EST
End payors in a generic drug price-fixing multidistrict litigation are seeking a Pennsylvania federal court's approval for a $66 million award of attorney fees, representing one-third of the $200 million settlement...
To view the full article, register now.